Kawasumi Laboratories, Incorporated【JP:E02310】
| Mar 31,
2013 | Mar 31,
2014 | Mar 31,
2015 | Mar 31,
2016 | Mar 31,
2017 | Mar 31,
2018 | Mar 31,
2019 | Mar 31,
2020 |
|---|
| Profit (loss) before income taxes | 1,332 | 1,085 | 1,749 | 2,160 | 1,017 | 733 | 409 | 1,940 |
|---|
| Depreciation | 2,524 | 2,697 | 2,108 | 1,833 | 1,620 | 1,689 | 1,631 | 1,555 |
|---|
| Impairment loss | - | 2,189 | 80 | - | - | - | 219 | 19 |
|---|
| Increase (decrease) in allowance for doubtful accounts | 4 | -2 | - | 12 | -12 | -17 | - | - |
|---|
| Increase (decrease) in provision for bonuses | -6 | -1 | -7 | 5 | -12 | -13 | -45 | -9 |
|---|
| Increase (decrease) in provision for bonuses for directors (and other officers) | - | 3 | 18 | -3 | - | -5 | -31 | 18 |
|---|
| Increase (decrease) in retirement benefit liability | - | 1,988 | 29 | 59 | 67 | 108 | -176 | 39 |
|---|
| Interest and dividend income | -38 | -25 | -40 | -66 | -68 | -80 | -109 | -87 |
|---|
| Interest expenses | 19 | 45 | 2 | 1 | 1 | 1 | 1 | 1 |
|---|
| Foreign exchange losses (gains) | -20 | 2 | 12 | 35 | 73 | -8 | -20 | 20 |
|---|
| Share of loss (profit) of entities accounted for using equity method | -5 | 17 | -17 | -41 | -28 | -7 | -6 | -7 |
|---|
| Loss (gain) on sales and retirement of property, plant and equipment | 70 | 111 | 5 | 16 | 31 | 55 | -47 | -183 |
|---|
| Loss (gain) on sales of investment securities | -8 | - | - | - | -25 | - | -1,245 | -1,063 |
|---|
| Decrease (increase) in trade receivables | 767 | 651 | 141 | -214 | 838 | -324 | 563 | 939 |
|---|
| Decrease (increase) in inventories | -841 | 898 | -148 | 544 | 187 | 155 | 344 | 428 |
|---|
| Decrease (increase) in other assets | 234 | -225 | 22 | 91 | -316 | 120 | -167 | -24 |
|---|
| Increase (decrease) in trade payables | -888 | -380 | 131 | -394 | -81 | -50 | 22 | -548 |
|---|
| Increase (decrease) in other liabilities | 28 | 94 | -15 | -469 | 107 | 174 | 299 | -372 |
|---|
| Subtotal | 2,429 | 4,426 | 4,072 | 3,571 | 3,401 | 2,532 | 1,639 | 2,663 |
|---|
| Interest and dividends received | 40 | 31 | 34 | 55 | 62 | 95 | 108 | 92 |
|---|
| Interest paid | -20 | -45 | -2 | -1 | -1 | -1 | -1 | -1 |
|---|
| Income taxes (paid) refund | - | - | - | - | -515 | 134 | -352 | -420 |
|---|
| Net cash provided by (used in) operating activities | 3,312 | 4,572 | 5,059 | 3,225 | 2,947 | 2,760 | 1,392 | 2,335 |
|---|
| Payments into time deposits | - | -111 | -346 | -19 | -25 | - | -50 | - |
|---|
| Proceeds from withdrawal of time deposits | - | - | 229 | 100 | - | - | 217 | 31 |
|---|
| Purchase of property, plant and equipment | -4,204 | -3,418 | -656 | -288 | -2,072 | -657 | -634 | -1,481 |
|---|
| Proceeds from sales of property, plant and equipment | - | 36 | 3 | 81 | 13 | 1 | 146 | 277 |
|---|
| Purchase of intangible assets | -87 | -16 | -69 | -45 | -381 | -60 | -85 | -175 |
|---|
| Proceeds from sales of investment securities | 64 | - | - | - | 30 | - | 2,120 | 1,588 |
|---|
| Other, net | 16 | 29 | -4 | -42 | 15 | - | 5 | -6 |
|---|
| Net cash provided by (used in) investing activities | -4,217 | -3,785 | -844 | -221 | -2,418 | -1,228 | 1,718 | 234 |
|---|
| Purchase of treasury shares | - | - | - | - | - | - | -860 | - |
|---|
| Dividends paid | -342 | -342 | -343 | -343 | -324 | -381 | -317 | -317 |
|---|
| Dividends paid to non-controlling interests | - | - | -2 | -3 | -2 | -2 | -1 | -12 |
|---|
| Repayments of finance lease obligations | -22 | -20 | -19 | -11 | -1 | -1 | -3 | -7 |
|---|
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation | - | - | - | - | - | - | -69 | - |
|---|
| Net cash provided by (used in) financing activities | -368 | -365 | -365 | -1,358 | -329 | -385 | -1,252 | -337 |
|---|
| Effect of exchange rate change on cash and cash equivalents | 403 | 48 | 175 | -303 | 6 | 138 | 148 | -110 |
|---|
| Net increase (decrease) in cash and cash equivalents | -870 | 470 | 4,024 | 1,342 | 206 | 1,285 | 2,007 | 2,121 |
|---|